Altre lingue ReShape Lifesciences Inc.

Azioni

RSLS

US76090R2004

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:01 03/05/2024			Variaz. 5gg	Var. 1 gen.
0,1693 ^USD	-3,42%		-0,29%	-32,20%

01/04	Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024
01/04	ReShape Lifesciences Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

North American Morning Briefing : Big Banks Kick -2-	12/04
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update	01/04
ReShape Lifesciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Certain Restricted Stock Units of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	30/03
Certain Warrants of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	30/03
Certain Options of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	30/03
Certain Common Stock of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.	30/03
ReShape Lifesciences Gets US Patent for Intragastric Balloon Weight-Loss System	28/03
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System	28/03
ReShape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to Intragastric Balloon System	28/03
ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX	04/03
ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX	22/02
Reshape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band 2.0 Flex	22/02
ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX	24/01
ReShape Lifesciences announces FDA PMA supplement approval for next-gen Lap-Band 2.0 Flex	21/12
ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives	20/12
Wall Street op nieuwe jaarrecords gesloten	13/12
Top Midday Gainers	13/12
Wall Street in afwachting van rentebesluit	13/12
Licht hogere start voor Wall Street	13/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue ReShape Lifesciences Inc.

Azioni

RSLS

US76090R2004

Altre lingue

Filtri